Grant Papanek Julie
Director at DAWN
- Sold, on record
- $26.9M
- Dollars the filings state
- Form 4 sales
- 16
- Latest Mar 1, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- DAWNDay One Biopharmaceuticals, Inc.Director
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale DAWNUnusualSep 21 2022
Sold 613,603 shares at $18.55 ($11.4M)
Grant Julie Papanek, Director
Sold 6.8% of holdings ($168M position)8.5M shares left122.7x usual sizeFiling
- 2 Form 4 sale DAWNPlan not statedOct 4 +13 days
Sold 10,000 shares at $20.03 ($200k)
Grant Julie Papanek, Director
Sold 2.3% of holdings ($8.8M position)429,358 shares left2x usual sizeFiling
- 3 Form 4 sale DAWNPlan not statedNov 2 +29 days
Sold 10,000 shares at $20.03 ($200k)
Grant Julie Papanek, Director
Sold 2.3% of holdings ($8.6M position)419,358 shares left1.3x usual sizeFiling
- 4 Form 4 sale DAWNPlan not statedDec 2 +30 days
Sold 10,000 shares at $21.65 ($216k)
Grant Julie Papanek, Director
Sold 2.4% of holdings ($9.1M position)409,358 shares left1x usual sizeFiling
- 5 Form 4 sale DAWNPlan not statedDec 8 +6 days
Sold 4,358 shares at $22.08 ($96k)
Grant Julie Papanek, Director
Sold 1.1% of holdings ($9M position)405,000 shares left0.4x usual sizeFiling
- 6 Form 4 sale DAWNPlan not statedJan 3 +26 days
Sold 25,000 shares at $20.65 ($516k)
Grant Julie Papanek, Director
Sold 6.2% of holdings ($8.4M position)380,000 shares left2.5x usual sizeFiling
- 7 Form 4 sale DAWNPlan not statedFeb 1 +29 days
Sold 25,000 shares at $21.23 ($531k)
Grant Julie Papanek, Director
Sold 6.6% of holdings ($8.1M position)355,000 shares left2.5x usual sizeFiling
- 8 Form 4 sale DAWNPlan not statedMar 1 +28 days
Sold 25,000 shares at $18.61 ($465k)
Grant Julie Papanek, Director
Sold 7% of holdings ($6.6M position)330,000 shares left2.5x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (16)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2023 | DAWN | Director | Form 4 sale | 25,000 | $465k | 7.0% | Plan not stated | SEC |
| Feb 1, 2023 | DAWN | Director | Form 4 sale | 25,000 | $531k | 6.6% | Plan not stated | SEC |
| Jan 3, 2023 | DAWN | Director | Form 4 sale | 25,000 | $516k | 6.2% | Plan not stated | SEC |
| Dec 8, 2022 | DAWN | Director | Form 4 sale | 4,358 | $96k | 1.1% | Plan not stated | SEC |
| Dec 2, 2022 | DAWN | Director | Form 4 sale | 10,000 | $216k | 2.4% | Plan not stated | SEC |
| Nov 2, 2022 | DAWN | Director | Form 4 sale | 10,000 | $200k | 2.3% | Plan not stated | SEC |
| Oct 4, 2022 | DAWN | Director | Form 4 sale | 10,000 | $200k | 2.3% | Plan not stated | SEC |
| Sep 21, 2022 | DAWN | Director | Form 4 sale | 613,603 | $11.4M | 6.8% | Unusual | SEC |
| Sep 20, 2022 | DAWN | Director | Form 4 sale | 340,702 | $7M | 3.6% | Unusual | SEC |
| Sep 15, 2022 | DAWN | Director | Form 4 sale | 245,039 | $5.8M | 2.5% | Unusual | SEC |
| Sep 2, 2022 | DAWN | Director | Form 4 sale | 5,000 | $119k | 1.1% | Plan not stated | SEC |
| Sep 1, 2022 | DAWN | Director | Form 4 sale | 5,000 | $116k | 1.1% | Plan not stated | SEC |
| Aug 5, 2022 | DAWN | Director | Form 4 sale | 10,000 | $200k | 2.2% | Unusual | SEC |
| Jul 18, 2022 | DAWN | Director | Form 4 sale | 2,600 | $52k | 0.6% | Plan not stated | SEC |
| Jul 8, 2022 | DAWN | Director | Form 4 sale | 1,242 | $25k | 0.3% | Plan not stated | SEC |
| Jul 5, 2022 | DAWN | Director | Form 4 sale | 1,800 | $36k | 0.4% | Plan not stated | SEC |